LIFU Mechanisms for PTSD in Healthcare Workers

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorLaureate Institute for Brain Research, Inc.

About this trial

The goal of this clinical trial is to evaluate whether low-intensity focused ultrasound (LIFU) of the ventral anterior cingulate cortex (vACC) can normalize dysfunctional brain activation patterns and behaviors in frontline healthcare workers with post-traumatic stress disorder. The main questions it aims to answer are:

* Does LIFU of the vACC effect activity and connectivity of the vACC and amygdala? * Does LIFU of the vACC reduce post-traumatic stress symptoms? Researchers will compare LIFU to sham modulation to see if LIFU modulates activity of vACC-amygdala circuitry and affects threat sensitivity and emotion regulation.

Participants will:

* Complete two fMRI sessions (before and after LIFU) * Receive a single session of LIFU or sham modulation of the vACC * Wear a wearable device that tracks sleep and heart rate metrics

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults in a frontline healthcare position (e.g. emergency medical services)

Ages 18-65 years

PTSD Checklist for DSM-5 (PCL-5) score ≥ 33 and < 65, OR at least partial PTSD as measured by the MINI

English proficiency as evaluated by language ability during screening

Disqualifiers

Neurological disorders

DSM-5 diagnosis of psychotic disorders, eating disorder, obsessive-compulsive disorder, moderate to severe alcohol or substance use disorder within the past year, bipolar disorder, or major depressive disorder with psychosis

Suicidal intent or plan (as measured by Suicide-Risk-Assessment-C-SSRS "Yes" answers to items 3, 4 or 5 of Suicidal Ideation-Past 1 month section, or any "Yes" answer to any of the items of Suicidal Behavior-Past 3 months section), or any suicide attempt in the last 3 months.

History of severe traumatic brain injury (as indicated by score ≥ 3 on the Tulsa Head Injury Screen) or of skull fractures

Trial design

Design model

Parallel

Treatments tested in this trial

  • Low intensity focused ultrasound

    Device

    Low intensity focused ultrasound neuromodulation of the ventral anterior cingulate cortex

  • Sham modulation

    Device

    Low intensity focused ultrasound with a Sorbothane membrane cover to prevent acoustic energy transmission

Treatment groups

66 Participants
are divided into 2 treatment groups
Group A: Low intensity focused ultrasound (LIFU)Experimental treatment 1 intervention
Group B: ShamSham comparator 1 intervention

Trial outcomes

Primary outcomes

1

LIFU target engagement

Percent BOLD signal change in vACC and amygdala regions of interest

Time frame
Study day 1 to day 7 (plus or minus 3 days)
2

Behavioral changes

Change in reaction time (ms) and error rate (percentage of correct answers) on emotional conflict task; difference between optimal and observed flight initiation distance.

Time frame
Day 0 to Day 7 (plus or minus 3 days)

Secondary outcomes

1

LIFU effects on physiology

Change in heart rate variability (ms), change in resting heart rate (beats per minute), change in %REM sleep (minutes), change in %deep sleep (minutes) as measured by Oura Ring

Time frame
Day 0 to day 14 (plus or minus 6 days)
2

LIFU effects on PTSD symptoms

Change in PCL-5 score

Time frame
Dy 0 to day 14 (plus or minus 6)
3

fMRI-heart rate variability correlation

Correlations between vACC/amygdala BOLD signal extracted beta-weights and heart rate variability (ms) as measured by Oura Ring

Time frame
Day 0 to day 14 (plus or minus 6)
4

fMRI-resting heart rate correlation

Correlations between vACC/amygdala BOLD signal extracted beta-weights and resting heart rate (beats per minute) as measured by Oura ring

Time frame
Day 0 to day 14 (plus or minus 6)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.